News of new drugs being developed by local companies are coming in one after another from early on this year.

Dong-A ST, which had developed three new drugs including the erectile dysfunction treatment ‘Zydena (udenafil),’ antibiotic ‘Sivestro (tedizolid phosphate),’ and antidiabetic ‘Suganon (evogliptin),’ is also receiving attention with its new drug candidate entering final stages of commercialization.

The Ministry of Food and Drug Safety approved the Phase III study protocol for Dong-A ST’s 'DA-8010,’ a new drug candidate in development for the treatment of overactive bladder syndrome.

The Phase III trial will be conducted to test the efficacy and safety of DA-8